Navigation Links
Ampyra is First Symptom Management Drug Developed Specifically to Treat MS, the First Oral MS Therapy Approved for MS, and the First New FDA Approved Therapy to Come Through the MS Pipeline Since 2004
Date:1/23/2010

15='82436582';s.tl(this,'o','ExternalLink');" target='_blank' href="http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(09)60442-6/abstract">http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(09)60442-6/abstract), summarized here: (http://www.nationalmssociety.org/research/research-news/news-detail/index.aspx?nid=951). Results from a later, second phase III study involving 240 people with MS (http://www.nationalmssociety.org/research/research-news/news-detail/index.aspx?nid=237), announced in 2008, confirmed the benefits seen in the first, finding that a significantly greater proportion of people on the therapy had a consistent improvement in walking speed compared to those who took placebo. Among those taking Ampyra who improved in walking speed, there was a statistically significant improvement in leg strength.

Q. What are the potential side effects of Ampyra?

A. In the first phase III study, common adverse events (side effects) experienced more often by those on active treatment included back pain, dizziness, insomnia, fatigue, nausea and balance disorder. Two serious adverse events led participants to discontinue taking the drug (one case of anxiety and one seizure in a person who developed sepsis from a urinary tract infection). In the second phase III study, additional common adverse events in those on therapy included urinary tract infection, falls, and hea
'/>"/>

SOURCE National Multiple Sclerosis Society
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. First Coast Oncology Deploying Both Naviscan(TM) PEM and AccuBoost(TM) Assisted Therapy to Optimize Breast Cancer Treatment
2. New Life Agency, Inc. Joins Forces With The Diamond Institute and Walgreens Specialty Pharmacy to Introduce the Nations First In Vitro Fertilization Insurance Program
3. First ShelterBoxes Arrive in Port au Prince - Pictures and Footage
4. WorldHeart Announces First U.S. Implant of Levacor(TM) VAD Implant at INTEGRIS in Oklahoma City
5. Span-America Announces First Quarter Conference Call On The Internet
6. Elbit Imaging Announces InSightecs First Non-Invasive Technology for Treatment of Uterine Fibroids Awarded MHLW Approval in Japan
7. JDRF Forms Partnership With Animas to Develop First-Generation Automated System for Managing Type 1 Diabetes
8. First Non-Invasive Technology for Treatment of Uterine Fibroids Awarded MHLW Approval in Japan
9. BD Announces Live Webcast of First Fiscal Quarter Earnings Conference Call
10. Rochester Medical Announces First Quarter 2010 Earnings Conference Call Tuesday, January 26, 2010
11. CVS Caremarks MinuteClinic Becomes First Retail Clinic Provider to Achieve Consecutive Accreditation Awards From The Joint Commission
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... , Sept. 30, 2014 The Chinese wound ... population and rise in the incidence of lifestyle diseases, ... and in affordability of better quality of wound care ... market. Universal coverage of public health insurance schemes and ... stimulate demand. Based on the findings of primary and ...
(Date:9/30/2014)... Quebec , Sept. 30, 2014 Valeant ... TSX: VRX) today announced that the company,s ... Letter from the U.S. Food and Drug Administration (FDA) ... Company,s records with regards to Sculptra Aesthetic injectable, which ... Warning Letter pertains to the management of Valeant,s contract manufacturers ...
(Date:9/30/2014)... Sept. 30, 2014 The signing of ... and New Jersey Health Foundation (NJHF) to work ... care programs has been announced by Rodger ... Kessler Foundation and James M. Golubieski , ... "The experience of New Jersey Health Foundation in ...
Breaking Medicine Technology:China Wound Care Market 2China Wound Care Market 3Valeant Pharmaceuticals' Bridgewater Location Receives Warning Letter From FDA 2Kessler Foundation Partners with New Jersey Health Foundation To Start Innovative Companies To Change the Lives of People with Disabilities 2
... 2007 - Reata,Pharmaceuticals, Inc. today announced the ... Synthetic Triterpenoid programs in,the May 2007 issue ... article, "Triterpenoids and rexinoids as multifunctional,agents for ... researchers,and Reata scientific collaborators from the Dartmouth ...
... least,one-third of the time, the symptoms of bipolar ... children, it can be,difficult to distinguish bipolar symptoms ... issue of the Harvard Mental Health,Letter. , Children, ... cycle of distinct mood episodes of mania and ...
Cached Medicine Technology:Reata's Synthetic Triterpenoids Profiled in Nature Reviews Cancer 2Reata's Synthetic Triterpenoids Profiled in Nature Reviews Cancer 3Reata's Synthetic Triterpenoids Profiled in Nature Reviews Cancer 4Bipolar Disorder in Children Difficult to Diagnose, Reports the,Harvard Mental Health Letter 2
(Date:9/30/2014)... Palm Beach, Florida (PRWEB) September 30, 2014 ... the No. 1 selling beauty brand on Amazon.com. , ... Sellers in their respective beauty categories on Amazon.com,” said Craig ... available in the UK on Amazon.co.uk and Canada on Amazon.ca ... latest products, which just launched earlier last month, are already ...
(Date:9/30/2014)... of Dental Medicine have been awarded a $11.8 million, ... Craniofacial Research, part of the National Institutes of Health, ... cleft lip and cleft palate and to expand the ... and Pennsylvania. , Orofacial clefts (OFCs), which are ... form when a baby,s mouth doesn,t develop properly during ...
(Date:9/30/2014)... of Michigan are pleased to announce an agreement to ... and Endocrinology , which is now open for submissions ... 2015. , The journal is led by Editor-in-Chief, ... of Metabolism, Endocrinology, and Diabetes, at the University of ... an international Editorial Board. , Clinical Diabetes ...
(Date:9/30/2014)... as an unusual character from a "Seinfeld" episode or ... genetic disease called SCID, short for severe combined immunodeficiency, ... contact because their bodies, natural defenses are too weak ... than 2,000 new births each year worldwide, SCID is ... a human immunodeficiency virus HIV/AIDS. , Now, using ...
(Date:9/30/2014)... and cardiac muscles contain few stem cells, heart ... heart attack. Now Tel Aviv University researchers are ... tissue engineering. , Dr. Tal Dvir and his ... Biotechnology, Department of Materials Science and Engineering, and ... sophisticated micro- and nanotechnological tools ranging in ...
Breaking Medicine News(10 mins):Health News:OZ Naturals Now the No. 1 Selling Beauty Brand on Amazon.com 2Health News:OZ Naturals Now the No. 1 Selling Beauty Brand on Amazon.com 3Health News:Pitt team searches for genetic roots of cleft lip, palate 2Health News:BioMed Central to publish open access journal in collaboration with the University of Michigan 2Health News:Virginia Tech researchers discover potential biomarker to detect 'bubble boy' disorder 2Health News:Virginia Tech researchers discover potential biomarker to detect 'bubble boy' disorder 3Health News:A heartbeat away? Hybrid 'patch' could replace transplants 2
... of Medicine in St. Louis claim that many children ... Their finding is totally reverse of the claims that ... said that 50 percent of the children who could ... ,"What we found was somewhat surprising," says Richard ...
... Young teenagers believe pregnancy would help them form connections ... boyfriend or creating a family of their own.// ... there are advantages in attaining motherhood early in life. ... the current issue of Pediatrics. ...
... from the University of Maryland School of Medicine, Galantamine, ... disease finds// a new role, in protecting people from ... The basis for further development of a safe and ... including nerve agents that have been used in chemical ...
... was launched in China on 7th August,2006//. ,Cancer is ... of Health department’s report in May. It accounts for ... and lifestyle factors are responsible for 80% of the cancers ... Treatment extends the lives of 60% of the cancer patients ...
... the Oman government's permission to carry out surgeries and ... group's new centre in the Omani capital Muscat. ... green signal to start our operation theatres, Intensive Care ... in the Times of Oman newspaper quoted V.T. Saileswaran ...
... compound derived from red algae to be a potent inhibitor ... warts//. The study has been published in the July ... thickening agent, blocks the Human Papillomavirus (HPV) from sticking to ... compound is a more natural and less expensive way to ...
Cached Medicine News:Health News:ADHD Children Are Being Under-Medicated 2Health News:ADHD Children Are Being Under-Medicated 3Health News:Teens and Pregnancy 2Health News:Teens and Pregnancy 3Health News:Alzheimer's Drug can be Used to Treat Nerve Agent and Pesticide Poisoning 2Health News:Alzheimer's Drug can be Used to Treat Nerve Agent and Pesticide Poisoning 3Health News:New Cancer-Blocking Algae Found 2
... A lower cost alternative to Equalizers, the ... transfers between two different vessel configurations. With the ... can be quickly and easily adjusted for test ... Ergonomic Design for Unparalleled Comfort Pick ...
... The Equalizer With 384 Well Plate ... the revolutionary features of the original Equalizerexpandable and ... autoclavable components, and in-lab calibration capabilities. In addition, ... tips down to 4.5mm for loading and accessing ...
Packaging: Set includes: Eight-channel pipette (10.8 mm with 0.5-5.0 μl capacity) 25 PrismStrip 96 tips with rack 2 FlexPlates with a holder...
The Biopette E has a comfortable, ergonomic design. Fully motorized piston drive. Virtually eliminates pipetting forces. User-friendly operator interface. Simple, precise volume setting. Rechargelabl...
Medicine Products: